Caption Management, LLC Karuna Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$161.01 - $317.85 $14.8 Million - $29.3 Million	92,100 Added 921.0%	102,100 $32.3 Million
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $23.8 Million - $31.5 Million	-144,500 Reduced 93.53%	10,000 $1.69 Million
Q2 2023 Aug 14, 2023	SELL	$176.32 - $240.22 $8.02 Million - $10.9 Million	-45,500 Reduced 22.75%	154,500 $33.5 Million
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $30.7 Million - $38.8 Million	190,000 Added 1900.0%	200,000 $36.3 Million
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $618,950 - $1.39 Million	-5,000 Reduced 33.33%	10,000 $2.25 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $1.41 Million - $2.15 Million	15,000 New	15,000 $1.9 Million
Q4 2021 Feb 11, 2022	SELL	$110.64 - $159.4 $708,096 - $1.02 Million	-6,400 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$101.2 - $125.87 $870,320 - $1.08 Million	-8,600 Reduced 57.33%	6,400 $783,000
Q2 2021 Aug 16, 2021	BUY	$107.45 - $135.95 $1.61 Million - $2.04 Million	15,000 New	15,000 $1.71 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.